Cases of "attaching importance to the quality of medical products to achieve success" or "failing to attach importance to quality to lead to failure"

Beijing Saiwo Medical Products Co., Ltd. is a high-tech biomedical company specializing in the research, development, production and sales of rapid diagnostic instruments and reagents. Relying on a large number of domestic and foreign technical backbones and professionals, the company worked closely with well-known American bioscience experts to research and invent the gold standard rapid quantitative instrument and supporting reagents. The birth of gold-labeled rapid quantitative instrument solved the technical problem that gold-labeled reagents can only be qualitative but not quantitative at present, and provided simpler, more accurate and more intuitive clinical data for rapid diagnosis. Based on the scientific and realistic business philosophy and service as the purpose, the company strives to provide first-class quality products and perfect after-sales service and technical support for scientific research units and medical institutions. International exclusive: The world's first colloidal gold immunochromatographic quantitative analyzer and special reagent has been approved by the Food and Drug Administration, and it has obtained two national patents: national patent number ZL97242938.7 and national patent number ZL95 1 15525.3, with one success and one failure.